{"transactions":[{"id":711394,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"McDonnell Michael R.","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2026-07-10T17:08:03.000Z","date":"2026-07-08","kind":"grant","planned":false,"acquired":true,"shares":5733,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to this restricted stock unit award will vest in full on the earlier of May 6, 2027, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The shares subject to this restricted stock unit award will vest in full on the earlier of May 6, 2027, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service."}],"balance_after":5733,"derivative":{"underlying":"Common Stock","underlying_shares":5733},"source":{"system":"sec-edgar","filing":"0001682852-26-000139","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1121897/000168285226000139/form4.xml","form_type":"4"}},{"id":711393,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"McDonnell Michael R.","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2026-07-10T17:08:03.000Z","date":"2026-07-08","kind":"grant","planned":false,"acquired":true,"shares":1618,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this restricted stock unit award will vest in full on July 8, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The shares subject to this restricted stock unit award will vest in full on July 8, 2027."}],"balance_after":1618,"derivative":{"underlying":"Common Stock","underlying_shares":1618},"source":{"system":"sec-edgar","filing":"0001682852-26-000139","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1121897/000168285226000139/form4.xml","form_type":"4"}},{"id":711392,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"McDonnell Michael R.","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-10T17:08:03.000Z","date":"2026-07-08","kind":"grant","planned":false,"acquired":true,"shares":7415,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will become fully vested and exercisable on July 8, 2027."}],"balance_after":7415,"derivative":{"exercise_price":73.8,"expiration_date":"2036-07-08","underlying":"Common Stock","underlying_shares":7415},"source":{"system":"sec-edgar","filing":"0001682852-26-000139","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1121897/000168285226000139/form4.xml","form_type":"4"}},{"id":773446,"issuer":{"id":3858,"kind":"organization","name":"MERIT MEDICAL SYSTEMS INC","symbol":"MMSI"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"McDonnell Michael R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, No Par Value","published_at":"2026-05-19T22:02:55.000Z","date":"2026-05-18","kind":"grant","planned":false,"acquired":true,"shares":3457,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transaction involved the reporting person's receipt of a grant of 3,457 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2026 Equity Incentive Plan. The RSUs granted to the reporting person will vest on May 3, 2027. Vesting of the RSUs is subject to continued service to the issuer through the vesting date."}],"balance_after":9852,"source":{"system":"sec-edgar","filing":"0001121897-26-000002","document":"form4-05192026_100552.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/856982/000112189726000002/form4-05192026_100552.xml","form_type":"4"}},{"id":789336,"issuer":{"id":1707,"kind":"organization","name":"BAXTER INTERNATIONAL INC","symbol":"BAX"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"McDonnell Michael R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $1 par value","published_at":"2026-05-07T20:14:10.000Z","date":"2026-05-05","kind":"grant","planned":false,"acquired":true,"shares":12836,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant."}],"balance_after":14647,"source":{"system":"sec-edgar","filing":"0001628280-26-032141","document":"wk-form4_1778184846.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/10456/000162828026032141/wk-form4_1778184846.xml","form_type":"4"}},{"id":900129,"issuer":{"id":1707,"kind":"organization","name":"BAXTER INTERNATIONAL INC","symbol":"BAX"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"McDonnell Michael R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $1 par value","published_at":"2026-02-18T21:06:26.000Z","date":"2026-02-13","kind":"grant","planned":false,"acquired":true,"shares":1811,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant."}],"balance_after":1811,"source":{"system":"sec-edgar","filing":"0001628280-26-009023","document":"wk-form4_1771448783.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/10456/000162828026009023/wk-form4_1771448783.xml","form_type":"4"}},{"id":1126434,"issuer":{"id":3858,"kind":"organization","name":"MERIT MEDICAL SYSTEMS INC","symbol":"MMSI"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"McDonnell Michael R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, No Par Value","published_at":"2025-06-03T21:45:55.000Z","date":"2025-06-02","kind":"sale","planned":true,"acquired":false,"shares":1750,"price":94.51,"value":165392.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2025."}],"balance_after":6395,"source":{"system":"sec-edgar","filing":"0001415889-25-015452","document":"form4-06032025_090648.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/856982/000141588925015452/form4-06032025_090648.xml","form_type":"4"}},{"id":1126433,"issuer":{"id":3858,"kind":"organization","name":"MERIT MEDICAL SYSTEMS INC","symbol":"MMSI"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"McDonnell Michael R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, No Par Value","published_at":"2025-06-03T21:45:55.000Z","date":"2025-05-30","kind":"sale","planned":true,"acquired":false,"shares":1750,"price":94.3,"value":165025.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2025."}],"balance_after":8145,"source":{"system":"sec-edgar","filing":"0001415889-25-015452","document":"form4-06032025_090648.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/856982/000141588925015452/form4-06032025_090648.xml","form_type":"4"}},{"id":1144000,"issuer":{"id":3858,"kind":"organization","name":"MERIT MEDICAL SYSTEMS INC","symbol":"MMSI"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, No Par Value","published_at":"2025-05-19T22:48:29.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":2152,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transaction involved the reporting person's receipt of a grant of 2,152 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2018 Long-Term Incentive Plan. The RSUs vest on May 15, 2026. Vesting of the RSUs is subject to continued service to the issuer through the vesting date."}],"balance_after":9895,"source":{"system":"sec-edgar","filing":"0001415889-25-013718","document":"form4-05192025_100525.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/856982/000141588925013718/form4-05192025_100525.xml","form_type":"4"}},{"id":1272574,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-02-12T22:46:02.000Z","date":"2025-02-10","kind":"exercise","planned":false,"acquired":false,"shares":3257,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 10, 2022."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2025-02-10","underlying":"Common Stock","underlying_shares":3257},"source":{"system":"sec-edgar","filing":"0001127602-25-004459","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760225004459/form4.xml","form_type":"4"}},{"id":1272573,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-12T22:46:02.000Z","date":"2025-02-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":1371,"price":142.54,"value":195422.34,"ownership":{"direct":true},"balance_after":24341,"source":{"system":"sec-edgar","filing":"0001127602-25-004459","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760225004459/form4.xml","form_type":"4"}},{"id":1272572,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-12T22:46:02.000Z","date":"2025-02-10","kind":"exercise","planned":false,"acquired":true,"shares":3257,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":25712,"source":{"system":"sec-edgar","filing":"0001127602-25-004459","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760225004459/form4.xml","form_type":"4"}},{"id":1277559,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-02-10T23:59:01.000Z","date":"2025-02-07","kind":"exercise","planned":false,"acquired":false,"shares":2216,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in three (3) equal annual installments, commencing one year after the grant date of 02/07/2024."}],"balance_after":4434,"derivative":{"exercise_price":0,"expiration_date":"2027-02-07","underlying":"Common Stock","underlying_shares":2216},"source":{"system":"sec-edgar","filing":"0001127602-25-003964","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760225003964/form4.xml","form_type":"4"}},{"id":1277558,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-02-10T23:59:01.000Z","date":"2025-02-07","kind":"exercise","planned":false,"acquired":false,"shares":2335,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 02/8/2023."}],"balance_after":2335,"derivative":{"exercise_price":0,"expiration_date":"2026-02-08","underlying":"Common Stock","underlying_shares":2335},"source":{"system":"sec-edgar","filing":"0001127602-25-003964","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760225003964/form4.xml","form_type":"4"}},{"id":1277557,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-10T23:59:01.000Z","date":"2025-02-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":716,"price":141.35,"value":101206.6,"ownership":{"direct":true},"balance_after":22455,"source":{"system":"sec-edgar","filing":"0001127602-25-003964","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760225003964/form4.xml","form_type":"4"}},{"id":1277556,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-10T23:59:01.000Z","date":"2025-02-07","kind":"exercise","planned":false,"acquired":true,"shares":2216,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":23171,"source":{"system":"sec-edgar","filing":"0001127602-25-003964","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760225003964/form4.xml","form_type":"4"}},{"id":1277555,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-10T23:59:01.000Z","date":"2025-02-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":786,"price":141.35,"value":111101.1,"ownership":{"direct":true},"balance_after":20955,"source":{"system":"sec-edgar","filing":"0001127602-25-003964","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760225003964/form4.xml","form_type":"4"}},{"id":1277554,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-10T23:59:01.000Z","date":"2025-02-07","kind":"exercise","planned":false,"acquired":true,"shares":2335,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":21741,"source":{"system":"sec-edgar","filing":"0001127602-25-003964","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760225003964/form4.xml","form_type":"4"}},{"id":1509727,"issuer":{"id":3858,"kind":"organization","name":"MERIT MEDICAL SYSTEMS INC","symbol":"MMSI"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, No Par Value","published_at":"2024-05-20T21:53:02.000Z","date":"2024-05-16","kind":"grant","planned":false,"acquired":true,"shares":2431,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transaction involved the reporting person's receipt of a grant of 2,431 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2018 Long-Term Incentive Plan. The RSUs vest on May 16, 2025. Vesting of the RSUs is subject to continued service to the issuer through the vesting date."}],"balance_after":7743,"source":{"system":"sec-edgar","filing":"0001415889-24-013816","document":"form4-05202024_090554.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/856982/000141588924013816/form4-05202024_090554.xml","form_type":"4"}},{"id":1630979,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-02-22T02:29:48.000Z","date":"2024-02-16","kind":"other","planned":false,"acquired":false,"shares":2684,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award was granted to the reporting person on February 18, 2021. The number of RSUs reported represented the maximum possible number of shares that were eligible for vesting, which is 200% of the number of shares at target\npayout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common\nstock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing\nstock price following and including the grant date])."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":2684},"source":{"system":"sec-edgar","filing":"0001127602-24-006214","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224006214/form4.xml","form_type":"4"}},{"id":1630978,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-02-22T02:29:48.000Z","date":"2024-02-16","kind":"exercise","planned":false,"acquired":false,"shares":2152,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award was granted to the reporting person on February 18, 2021. The number of RSUs reported represented the maximum possible number of shares that were eligible for vesting, which is 200% of the number of shares at target\npayout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common\nstock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing\nstock price following and including the grant date])."}],"balance_after":2684,"derivative":{"exercise_price":0,"expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":2152},"source":{"system":"sec-edgar","filing":"0001127602-24-006214","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224006214/form4.xml","form_type":"4"}},{"id":1630977,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Performance Stock Unit","published_at":"2024-02-22T02:29:48.000Z","date":"2024-02-16","kind":"exercise","planned":false,"acquired":false,"shares":4568,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2024-02-18","expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":4568},"source":{"system":"sec-edgar","filing":"0001127602-24-006214","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224006214/form4.xml","form_type":"4"}},{"id":1630976,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-02-22T02:29:48.000Z","date":"2024-02-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":1101,"price":219.08,"value":241207.08,"ownership":{"direct":true},"balance_after":19406,"source":{"system":"sec-edgar","filing":"0001127602-24-006214","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224006214/form4.xml","form_type":"4"}},{"id":1630975,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-02-22T02:29:48.000Z","date":"2024-02-16","kind":"exercise","planned":false,"acquired":true,"shares":2152,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":20507,"source":{"system":"sec-edgar","filing":"0001127602-24-006214","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224006214/form4.xml","form_type":"4"}},{"id":1630974,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-02-22T02:29:48.000Z","date":"2024-02-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":2337,"price":219.08,"value":511989.96,"ownership":{"direct":true},"balance_after":18355,"source":{"system":"sec-edgar","filing":"0001127602-24-006214","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224006214/form4.xml","form_type":"4"}},{"id":1630973,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-02-22T02:29:48.000Z","date":"2024-02-16","kind":"exercise","planned":false,"acquired":true,"shares":4568,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":20692,"source":{"system":"sec-edgar","filing":"0001127602-24-006214","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224006214/form4.xml","form_type":"4"}},{"id":1647463,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-02-13T23:03:10.000Z","date":"2024-02-09","kind":"exercise","planned":false,"acquired":false,"shares":3257,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 10, 2022."}],"balance_after":3257,"derivative":{"exercise_price":0,"expiration_date":"2025-02-10","underlying":"Common Stock","underlying_shares":3257},"source":{"system":"sec-edgar","filing":"0001127602-24-004799","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224004799/form4.xml","form_type":"4"}},{"id":1647462,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-02-13T23:03:10.000Z","date":"2024-02-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":1431,"price":240.98,"value":344842.38,"ownership":{"direct":true},"balance_after":16124,"source":{"system":"sec-edgar","filing":"0001127602-24-004799","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224004799/form4.xml","form_type":"4"}},{"id":1647461,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-02-13T23:03:10.000Z","date":"2024-02-09","kind":"exercise","planned":false,"acquired":true,"shares":3257,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":17555,"source":{"system":"sec-edgar","filing":"0001127602-24-004799","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224004799/form4.xml","form_type":"4"}},{"id":1652216,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-02-10T01:03:26.000Z","date":"2024-02-08","kind":"exercise","planned":false,"acquired":false,"shares":2335,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 02/8/2023."}],"balance_after":4670,"derivative":{"exercise_price":0,"expiration_date":"2026-02-08","underlying":"Common Stock","underlying_shares":2335},"source":{"system":"sec-edgar","filing":"0001127602-24-004305","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224004305/form4.xml","form_type":"4"}},{"id":1652215,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-02-10T01:03:26.000Z","date":"2024-02-07","kind":"grant","planned":false,"acquired":true,"shares":6650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three (3) equal annual installments, commencing one year after the grant date of 02/07/2024."}],"balance_after":6650,"derivative":{"exercise_price":0,"expiration_date":"2027-02-07","underlying":"Common Stock","underlying_shares":6650},"source":{"system":"sec-edgar","filing":"0001127602-24-004305","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224004305/form4.xml","form_type":"4"}},{"id":1652214,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-02-10T01:03:26.000Z","date":"2024-02-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":765,"price":240.3,"value":183829.5,"ownership":{"direct":true},"balance_after":14298,"source":{"system":"sec-edgar","filing":"0001127602-24-004305","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224004305/form4.xml","form_type":"4"}},{"id":1652213,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-02-10T01:03:26.000Z","date":"2024-02-08","kind":"exercise","planned":false,"acquired":true,"shares":2335,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":15063,"source":{"system":"sec-edgar","filing":"0001127602-24-004305","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224004305/form4.xml","form_type":"4"}},{"id":1665790,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Performance Stock Unit","published_at":"2024-01-31T22:34:17.000Z","date":"2024-01-29","kind":"grant","planned":false,"acquired":true,"shares":4568,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares earned upon satisfaction of certain performance conditions associated with performance stock units granted on February 18, 2021. The PSUs will vest on February 18, 2024."}],"balance_after":4568,"derivative":{"exercise_price":0,"exercise_date":"2024-02-18","expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":4568},"source":{"system":"sec-edgar","filing":"0001127602-24-002810","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224002810/form4.xml","form_type":"4"}},{"id":1788070,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2023-09-06T22:08:13.000Z","date":"2023-09-01","kind":"other","planned":false,"acquired":false,"shares":2763,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the average closing stock price for the 30 calendar days following and including the grant date and 30 calendar days prior to and including such vesting date])."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2023-09-01","underlying":"Common Stock","underlying_shares":2763},"source":{"system":"sec-edgar","filing":"0001127602-23-023825","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223023825/form4.xml","form_type":"4"}},{"id":1788069,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2023-09-06T22:08:13.000Z","date":"2023-09-01","kind":"exercise","planned":false,"acquired":false,"shares":2603,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the average closing stock price for the 30 calendar days following and including the grant date and 30 calendar days prior to and including such vesting date])."}],"balance_after":2763,"derivative":{"exercise_price":0,"expiration_date":"2023-09-01","underlying":"Common Stock","underlying_shares":2603},"source":{"system":"sec-edgar","filing":"0001127602-23-023825","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223023825/form4.xml","form_type":"4"}},{"id":1788068,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2023-09-06T22:08:13.000Z","date":"2023-09-01","kind":"exercise","planned":false,"acquired":false,"shares":2682,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vested in three (3) equal annual installments commencing one year after the grant date of 09/01/2020."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2023-09-01","underlying":"Common Stock","underlying_shares":2682},"source":{"system":"sec-edgar","filing":"0001127602-23-023825","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223023825/form4.xml","form_type":"4"}},{"id":1788067,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-09-06T22:08:13.000Z","date":"2023-09-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":1332,"price":267.17,"value":355870.44,"ownership":{"direct":true},"balance_after":12728,"source":{"system":"sec-edgar","filing":"0001127602-23-023825","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223023825/form4.xml","form_type":"4"}},{"id":1788066,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-09-06T22:08:13.000Z","date":"2023-09-01","kind":"exercise","planned":false,"acquired":true,"shares":2603,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":14060,"source":{"system":"sec-edgar","filing":"0001127602-23-023825","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223023825/form4.xml","form_type":"4"}},{"id":1788065,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-09-06T22:08:13.000Z","date":"2023-09-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":1372,"price":267.17,"value":366557.24,"ownership":{"direct":true},"balance_after":11457,"source":{"system":"sec-edgar","filing":"0001127602-23-023825","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223023825/form4.xml","form_type":"4"}},{"id":1788064,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-09-06T22:08:13.000Z","date":"2023-09-01","kind":"exercise","planned":false,"acquired":true,"shares":2682,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":12829,"source":{"system":"sec-edgar","filing":"0001127602-23-023825","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223023825/form4.xml","form_type":"4"}},{"id":1883431,"issuer":{"id":3858,"kind":"organization","name":"MERIT MEDICAL SYSTEMS INC","symbol":"MMSI"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, No Par Value","published_at":"2023-05-22T18:47:31.000Z","date":"2023-05-18","kind":"grant","planned":false,"acquired":true,"shares":2262,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transaction involved the reporting person's receipt of a grant of 2,262 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2018 Long-Term Incentive Plan. The RSUs vest on May 18, 2024. Vesting of the RSUs is subject to continued service to the issuer through the vesting date."}],"balance_after":5312,"source":{"system":"sec-edgar","filing":"0001415889-23-008483","document":"form4-05222023_060528.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/856982/000141588923008483/form4-05222023_060528.xml","form_type":"4"}},{"id":2001577,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2023-02-22T22:03:41.000Z","date":"2023-02-17","kind":"other","acquired":false,"shares":2271,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award was granted to the reporting person on February 18, 2021. The number of RSUs reported represented the maximum possible number of shares that were eligible for vesting, which is 200% of the number of shares at target\npayout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common\nstock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing\nstock price following and including the grant date])."}],"balance_after":4836,"derivative":{"exercise_price":0,"expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":2271},"source":{"system":"sec-edgar","filing":"0001127602-23-006522","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223006522/form4.xml","form_type":"4"}},{"id":2001576,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2023-02-22T22:03:41.000Z","date":"2023-02-17","kind":"exercise","acquired":false,"shares":2561,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award was granted to the reporting person on February 18, 2021. The number of RSUs reported represented the maximum possible number of shares that were eligible for vesting, which is 200% of the number of shares at target\npayout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common\nstock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing\nstock price following and including the grant date])."}],"balance_after":7107,"derivative":{"exercise_price":0,"expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":2561},"source":{"system":"sec-edgar","filing":"0001127602-23-006522","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223006522/form4.xml","form_type":"4"}},{"id":2001575,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-02-22T22:03:41.000Z","date":"2023-02-17","kind":"tax_withholding","acquired":false,"shares":1310,"price":278.38,"value":364677.8,"ownership":{"direct":true},"balance_after":7586,"source":{"system":"sec-edgar","filing":"0001127602-23-006522","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223006522/form4.xml","form_type":"4"}},{"id":2001574,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-02-22T22:03:41.000Z","date":"2023-02-17","kind":"exercise","acquired":true,"shares":2561,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10147,"source":{"system":"sec-edgar","filing":"0001127602-23-006522","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223006522/form4.xml","form_type":"4"}},{"id":2017908,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2023-02-15T02:25:29.000Z","date":"2023-02-10","kind":"exercise","acquired":false,"shares":3256,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 10, 2022."}],"balance_after":6514,"derivative":{"exercise_price":0,"expiration_date":"2025-02-10","underlying":"Common Stock","underlying_shares":3256},"source":{"system":"sec-edgar","filing":"0001127602-23-005269","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223005269/form4.xml","form_type":"4"}},{"id":2017907,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-02-15T02:25:29.000Z","date":"2023-02-10","kind":"tax_withholding","acquired":false,"shares":1105,"price":286.3,"value":316361.5,"ownership":{"direct":true},"balance_after":8896,"source":{"system":"sec-edgar","filing":"0001127602-23-005269","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223005269/form4.xml","form_type":"4"}},{"id":2017906,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-02-15T02:25:29.000Z","date":"2023-02-10","kind":"exercise","acquired":true,"shares":3256,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10001,"source":{"system":"sec-edgar","filing":"0001127602-23-005269","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223005269/form4.xml","form_type":"4"}},{"id":2023667,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2023-02-10T23:48:45.000Z","date":"2023-02-08","kind":"grant","acquired":true,"shares":7005,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 02/8/2023."}],"balance_after":7005,"derivative":{"exercise_price":0,"expiration_date":"2026-02-08","underlying":"Common Stock","underlying_shares":7005},"source":{"system":"sec-edgar","filing":"0001127602-23-004579","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223004579/form4.xml","form_type":"4"}},{"id":2166565,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2022-09-06T23:31:49.000Z","date":"2022-09-01","kind":"other","acquired":false,"shares":3298,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout.  One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date.  The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date])."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."}],"balance_after":5366,"derivative":{"exercise_price":0,"expiration_date":"2023-09-01","underlying":"Common Stock","underlying_shares":3298},"source":{"system":"sec-edgar","filing":"0001127602-22-022132","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222022132/form4.xml","form_type":"4"}},{"id":2166564,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2022-09-06T23:31:49.000Z","date":"2022-09-01","kind":"exercise","acquired":false,"shares":2064,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout.  One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date.  The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date])."}],"balance_after":8664,"derivative":{"exercise_price":0,"expiration_date":"2023-09-01","underlying":"Common Stock","underlying_shares":2064},"source":{"system":"sec-edgar","filing":"0001127602-22-022132","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222022132/form4.xml","form_type":"4"}},{"id":2166563,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2022-09-06T23:31:49.000Z","date":"2022-09-01","kind":"exercise","acquired":false,"shares":2682,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 09/01/2020."}],"balance_after":2682,"derivative":{"exercise_price":0,"expiration_date":"2023-09-01","underlying":"Common Stock","underlying_shares":2682},"source":{"system":"sec-edgar","filing":"0001127602-22-022132","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222022132/form4.xml","form_type":"4"}},{"id":2166562,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-09-06T23:31:49.000Z","date":"2022-09-01","kind":"tax_withholding","acquired":false,"shares":1056,"price":199.79,"value":210978.24,"ownership":{"direct":true},"balance_after":6745,"source":{"system":"sec-edgar","filing":"0001127602-22-022132","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222022132/form4.xml","form_type":"4"}},{"id":2166561,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-09-06T23:31:49.000Z","date":"2022-09-01","kind":"exercise","acquired":true,"shares":2064,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout.  One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date.  The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date])."}],"balance_after":7801,"source":{"system":"sec-edgar","filing":"0001127602-22-022132","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222022132/form4.xml","form_type":"4"}},{"id":2166560,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-09-06T23:31:49.000Z","date":"2022-09-01","kind":"tax_withholding","acquired":false,"shares":1372,"price":199.79,"value":274111.88,"ownership":{"direct":true},"balance_after":5737,"source":{"system":"sec-edgar","filing":"0001127602-22-022132","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222022132/form4.xml","form_type":"4"}},{"id":2166559,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-09-06T23:31:49.000Z","date":"2022-09-01","kind":"exercise","acquired":true,"shares":2682,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 09/01/2020."}],"balance_after":7109,"source":{"system":"sec-edgar","filing":"0001127602-22-022132","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222022132/form4.xml","form_type":"4"}},{"id":2256024,"issuer":{"id":3858,"kind":"organization","name":"MERIT MEDICAL SYSTEMS INC","symbol":"MMSI"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, No Par Value","published_at":"2022-05-26T22:33:50.000Z","date":"2022-05-24","kind":"grant","acquired":true,"shares":3050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transaction involved the reporting person's receipt of a grant of 3,050 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2018 Long-Term Incentive Plan. The RSUs vest on May 24, 2023. Vesting of the RSUs is subject to continued service to the issuer through the vesting date."}],"balance_after":3050,"source":{"system":"sec-edgar","filing":"0001415889-22-005723","document":"form4-05262022_030527.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/856982/000141588922005723/form4-05262022_030527.xml","form_type":"4"}},{"id":2380153,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2022-02-23T21:19:12.000Z","date":"2022-02-18","kind":"other","acquired":false,"shares":2851,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout.  One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date.  The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date])."}],"balance_after":9668,"derivative":{"exercise_price":0,"expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":2851},"source":{"system":"sec-edgar","filing":"0001127602-22-006275","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222006275/form4.xml","form_type":"4"}},{"id":2380152,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2022-02-23T21:19:12.000Z","date":"2022-02-18","kind":"exercise","acquired":false,"shares":1981,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout.  One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date.  The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date])."}],"balance_after":12519,"derivative":{"exercise_price":0,"expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":1981},"source":{"system":"sec-edgar","filing":"0001127602-22-006275","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222006275/form4.xml","form_type":"4"}},{"id":2380151,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-02-23T21:19:12.000Z","date":"2022-02-18","kind":"tax_withholding","acquired":false,"shares":977,"price":209.79,"value":204964.83,"ownership":{"direct":true},"balance_after":4427,"source":{"system":"sec-edgar","filing":"0001127602-22-006275","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222006275/form4.xml","form_type":"4"}},{"id":2380150,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-02-23T21:19:12.000Z","date":"2022-02-18","kind":"exercise","acquired":true,"shares":1981,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5404,"source":{"system":"sec-edgar","filing":"0001127602-22-006275","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222006275/form4.xml","form_type":"4"}},{"id":2399480,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2022-02-14T21:22:36.000Z","date":"2022-02-10","kind":"grant","acquired":true,"shares":9770,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 10, 2022."}],"balance_after":9770,"derivative":{"exercise_price":0,"expiration_date":"2025-02-10","underlying":"Common Stock","underlying_shares":9770},"source":{"system":"sec-edgar","filing":"0001127602-22-004790","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222004790/form4.xml","form_type":"4"}},{"id":2580376,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2021-09-03T20:08:01.000Z","date":"2021-09-01","kind":"other","acquired":false,"shares":2038,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the average closing stock price for the 30 calendar days following and including the grant date and 30 calendar days prior to and including such vesting date])."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":10728,"derivative":{"exercise_price":0,"expiration_date":"2023-09-01","underlying":"Common Stock","underlying_shares":2038},"source":{"system":"sec-edgar","filing":"0001127602-21-024863","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221024863/form4.xml","form_type":"4"}},{"id":2580375,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2021-09-03T20:08:01.000Z","date":"2021-09-01","kind":"exercise","acquired":false,"shares":3324,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the average closing stock price for the 30 calendar days following and including the grant date and 30 calendar days prior to and including such vesting date])."}],"balance_after":12766,"derivative":{"exercise_price":0,"expiration_date":"2023-09-01","underlying":"Common Stock","underlying_shares":3324},"source":{"system":"sec-edgar","filing":"0001127602-21-024863","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221024863/form4.xml","form_type":"4"}},{"id":2580374,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2021-09-03T20:08:01.000Z","date":"2021-09-01","kind":"exercise","acquired":false,"shares":2681,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 09/01/2020."}],"balance_after":5364,"derivative":{"exercise_price":0,"expiration_date":"2023-09-01","underlying":"Common Stock","underlying_shares":2681},"source":{"system":"sec-edgar","filing":"0001127602-21-024863","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221024863/form4.xml","form_type":"4"}},{"id":2580373,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-09-03T20:08:01.000Z","date":"2021-09-01","kind":"tax_withholding","acquired":false,"shares":1441,"price":338.24,"value":487403.84,"ownership":{"direct":true},"balance_after":3423,"source":{"system":"sec-edgar","filing":"0001127602-21-024863","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221024863/form4.xml","form_type":"4"}},{"id":2580372,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-09-03T20:08:01.000Z","date":"2021-09-01","kind":"exercise","acquired":true,"shares":3324,"price":338.24,"value":1124309.76,"ownership":{"direct":true},"balance_after":4864,"source":{"system":"sec-edgar","filing":"0001127602-21-024863","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221024863/form4.xml","form_type":"4"}},{"id":2580371,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-09-03T20:08:01.000Z","date":"2021-09-01","kind":"tax_withholding","acquired":false,"shares":1141,"price":338.24,"value":385931.84,"ownership":{"direct":true},"balance_after":1540,"source":{"system":"sec-edgar","filing":"0001127602-21-024863","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221024863/form4.xml","form_type":"4"}},{"id":2580370,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-09-03T20:08:01.000Z","date":"2021-09-01","kind":"exercise","acquired":true,"shares":2681,"price":338.24,"value":906821.44,"ownership":{"direct":true},"balance_after":2681,"source":{"system":"sec-edgar","filing":"0001127602-21-024863","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221024863/form4.xml","form_type":"4"}},{"id":2844483,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2021-02-22T21:17:11.000Z","date":"2021-02-18","kind":"grant","acquired":true,"shares":14500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":14500,"derivative":{"exercise_price":0,"expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":14500},"source":{"system":"sec-edgar","filing":"0001127602-21-006995","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221006995/form4.xml","form_type":"4"}},{"id":3040163,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2020-09-03T21:17:55.000Z","date":"2020-09-01","kind":"grant","acquired":true,"shares":16090,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the average closing stock price for the 30 calendar days following and including the grant date and 30 calendar days prior to and including such vesting date])."}],"balance_after":16090,"derivative":{"exercise_price":0,"expiration_date":"2023-09-01","underlying":"Common Stock","underlying_shares":16090},"source":{"system":"sec-edgar","filing":"0001127602-20-024721","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220024721/form4.xml","form_type":"4"}},{"id":3040162,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2020-09-03T21:17:55.000Z","date":"2020-09-01","kind":"grant","acquired":true,"shares":8045,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 09/01/2020."}],"balance_after":8045,"derivative":{"exercise_price":0,"expiration_date":"2023-09-01","underlying":"Common Stock","underlying_shares":8045},"source":{"system":"sec-edgar","filing":"0001127602-20-024721","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220024721/form4.xml","form_type":"4"}},{"id":3087681,"issuer":{"id":3058,"kind":"organization","name":"IQVIA HOLDINGS INC.","symbol":"IQV"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2020-07-07T22:26:46.000Z","date":"2020-07-05","kind":"tax_withholding","acquired":false,"shares":2762,"price":141.52,"value":390878.24,"ownership":{"direct":true},"balance_after":18966,"source":{"system":"sec-edgar","filing":"0001478242-20-000040","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1121897/000147824220000040/primary_doc.xml","form_type":"4"}},{"id":3274635,"issuer":{"id":3058,"kind":"organization","name":"IQVIA HOLDINGS INC.","symbol":"IQV"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Stock Appreciation Right","published_at":"2020-02-13T22:13:36.000Z","date":"2020-02-11","kind":"grant","acquired":true,"shares":23897,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock appreciation right vests in three annual installments beginning on February 11, 2021."}],"balance_after":23897,"derivative":{"exercise_price":161.7,"expiration_date":"2030-02-11","underlying":"Common Stock","underlying_shares":23897},"source":{"system":"sec-edgar","filing":"0001478242-20-000012","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1121897/000147824220000012/edgar.xml","form_type":"4"}},{"id":3274634,"issuer":{"id":3058,"kind":"organization","name":"IQVIA HOLDINGS INC.","symbol":"IQV"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2020-02-13T22:13:36.000Z","date":"2020-02-11","kind":"tax_withholding","acquired":false,"shares":5366,"price":161.7,"value":867682.2,"ownership":{"direct":true},"balance_after":21728,"source":{"system":"sec-edgar","filing":"0001478242-20-000012","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1121897/000147824220000012/edgar.xml","form_type":"4"}},{"id":3274633,"issuer":{"id":3058,"kind":"organization","name":"IQVIA HOLDINGS INC.","symbol":"IQV"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2020-02-13T22:13:36.000Z","date":"2020-02-11","kind":"grant","acquired":true,"shares":12728,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 2, 2017.  The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on February 11, 2020."}],"balance_after":27094,"source":{"system":"sec-edgar","filing":"0001478242-20-000012","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1121897/000147824220000012/edgar.xml","form_type":"4"}},{"id":3318959,"issuer":{"id":3058,"kind":"organization","name":"IQVIA HOLDINGS INC.","symbol":"IQV"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2020-01-06T22:05:34.000Z","date":"2020-01-02","kind":"sale","acquired":false,"shares":12000,"price":155.07,"value":1860840.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 23, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $155.00 to $155.10 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":14366,"source":{"system":"sec-edgar","filing":"0001478242-20-000002","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1121897/000147824220000002/edgar.xml","form_type":"4"}},{"id":3465316,"issuer":{"id":3058,"kind":"organization","name":"IQVIA HOLDINGS INC.","symbol":"IQV"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2019-07-09T21:02:24.000Z","date":"2019-07-05","kind":"tax_withholding","acquired":false,"shares":2419,"price":160.9,"value":389217.1,"ownership":{"direct":true},"balance_after":26366,"source":{"system":"sec-edgar","filing":"0001478242-19-000035","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1121897/000147824219000035/edgar.xml","form_type":"4"}},{"id":3571232,"issuer":{"id":69025,"kind":"organization","name":"Frontier Communications Parent, Inc.","symbol":"FYBR"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"director":true}}],"security":"Phantom Stock Units","published_at":"2019-04-02T17:54:33.000Z","date":"2019-04-01","kind":"grant","acquired":true,"shares":14018.69,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Phantom stock units convert one-for-one into shares of common stock or cash equivalent, at the election of the Reporting Person, upon the Reporting Person's termination of service as a director of the Company."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Quarterly payment of portion of annual retainer paid in the form of phantom stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Phantom stock units convert one-for-one into shares of common stock or cash equivalent, at the election of the Reporting Person, upon the Reporting Person's termination of service as a director of the Company."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Phantom stock units convert one-for-one into shares of common stock or cash equivalent, at the election of the Reporting Person, upon the Reporting Person's termination of service as a director of the Company."}],"balance_after":28925.52,"derivative":{"underlying":"Common Stock","underlying_shares":14018.69},"source":{"system":"sec-edgar","filing":"0001127602-19-014279","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/20520/000112760219014279/form4.xml","form_type":"4"}},{"id":3654102,"issuer":{"id":3058,"kind":"organization","name":"IQVIA HOLDINGS INC.","symbol":"IQV"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Stock Appreciation Right","published_at":"2019-02-15T22:08:10.000Z","date":"2019-02-13","kind":"grant","acquired":true,"shares":23045,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock appreciation right vests in three annual installments beginning on 02/13/2020."}],"balance_after":23045,"derivative":{"exercise_price":131.82,"expiration_date":"2029-02-13","underlying":"Common Stock","underlying_shares":23045},"source":{"system":"sec-edgar","filing":"0001478242-19-000009","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1121897/000147824219000009/edgar.xml","form_type":"4"}},{"id":3712338,"issuer":{"id":69025,"kind":"organization","name":"Frontier Communications Parent, Inc.","symbol":"FYBR"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"director":true}}],"security":"Phantom Stock Units","published_at":"2019-01-03T17:09:13.000Z","date":"2019-01-02","kind":"grant","acquired":true,"shares":14906.83,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Phantom stock units convert one-for-one into shares of common stock or cash equivalent, at the election of the Reporting Person, upon the Reporting Person's termination of service as a director of the Company."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Quarterly payment of portion of annual retainer paid in the form of phantom stock units."},{"field":"shares","element":"transactionShares","label":"F3","text":"Includes payment of pro rata portion of 2018 annual retainer from date of election to the Board."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Phantom stock units convert one-for-one into shares of common stock or cash equivalent, at the election of the Reporting Person, upon the Reporting Person's termination of service as a director of the Company."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Phantom stock units convert one-for-one into shares of common stock or cash equivalent, at the election of the Reporting Person, upon the Reporting Person's termination of service as a director of the Company."}],"balance_after":14906.83,"derivative":{"underlying":"Common Stock","underlying_shares":14906.83},"source":{"system":"sec-edgar","filing":"0001127602-19-000829","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/20520/000112760219000829/form4.xml","form_type":"4"}},{"id":3741809,"issuer":{"id":3058,"kind":"organization","name":"IQVIA HOLDINGS INC.","symbol":"IQV"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2018-12-06T22:05:40.000Z","date":"2018-12-03","kind":"sale","acquired":false,"shares":9500,"price":128.35,"value":1219325.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August  24, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $127.05 to $129.00 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":28785,"source":{"system":"sec-edgar","filing":"0001478242-18-000062","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1121897/000147824218000062/edgar.xml","form_type":"4"}},{"id":3871270,"issuer":{"id":3058,"kind":"organization","name":"IQVIA HOLDINGS INC.","symbol":"IQV"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2018-07-09T20:24:47.000Z","date":"2018-07-05","kind":"tax_withholding","acquired":false,"shares":2232,"price":100.4,"value":224092.8,"ownership":{"direct":true},"balance_after":38285,"source":{"system":"sec-edgar","filing":"0001478242-18-000044","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1121897/000147824218000044/edgar.xml","form_type":"4"}},{"id":4066311,"issuer":{"id":3058,"kind":"organization","name":"IQVIA HOLDINGS INC.","symbol":"IQV"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Stock Appreciation Right","published_at":"2018-02-13T02:37:57.000Z","date":"2018-02-08","kind":"grant","acquired":true,"shares":26742,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock appreciation right vests in three annual installments beginning on 02/08/2019."}],"balance_after":26742,"derivative":{"exercise_price":95.23,"expiration_date":"2028-02-08","underlying":"Common Stock","underlying_shares":26742},"source":{"system":"sec-edgar","filing":"0001478242-18-000007","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1121897/000147824218000007/edgar.xml","form_type":"4"}},{"id":4261051,"issuer":{"id":3058,"kind":"organization","name":"IQVIA HOLDINGS INC.","symbol":"IQV"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2017-07-07T23:56:58.000Z","date":"2017-07-05","kind":"tax_withholding","acquired":false,"shares":16073,"price":89.16,"value":1433068.68,"ownership":{"direct":true},"balance_after":40517,"source":{"system":"sec-edgar","filing":"0001478242-17-000038","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1121897/000147824217000038/edgar.xml","form_type":"4"}},{"id":4261050,"issuer":{"id":3058,"kind":"organization","name":"IQVIA HOLDINGS INC.","symbol":"IQV"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2017-07-07T23:56:58.000Z","date":"2017-07-05","kind":"grant","acquired":true,"shares":16823,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units that will vest in three annual installments beginning on July 5, 2018."}],"balance_after":56590,"source":{"system":"sec-edgar","filing":"0001478242-17-000038","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1121897/000147824217000038/edgar.xml","form_type":"4"}},{"id":4261048,"issuer":{"id":174539,"kind":"organization","name":"IMS Health Holdings, Inc.","symbol":"Q"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2017-07-07T22:13:02.000Z","date":"2017-07-05","kind":"tax_withholding","acquired":false,"shares":16073,"price":89.16,"value":1433068.68,"ownership":{"direct":true},"balance_after":40517,"source":{"system":"sec-edgar","filing":"0001595262-17-000002","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1121897/000159526217000002/edgar.xml","form_type":"4"}},{"id":4261047,"issuer":{"id":174539,"kind":"organization","name":"IMS Health Holdings, Inc.","symbol":"Q"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2017-07-07T22:13:02.000Z","date":"2017-07-05","kind":"grant","acquired":true,"shares":16823,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units that will vest in three annual installments beginning on July 5, 2018."}],"balance_after":56590,"source":{"system":"sec-edgar","filing":"0001595262-17-000002","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1121897/000159526217000002/edgar.xml","form_type":"4"}},{"id":4466598,"issuer":{"id":3058,"kind":"organization","name":"IQVIA HOLDINGS INC.","symbol":"IQV"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Stock Appreciation Right","published_at":"2017-02-06T22:12:20.000Z","date":"2017-02-02","kind":"grant","acquired":true,"shares":26034,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock appreciation right vests in three annual installments beginning on 02/02/2018."}],"balance_after":26034,"derivative":{"exercise_price":78.21,"expiration_date":"2027-02-02","underlying":"Common Stock","underlying_shares":26034},"source":{"system":"sec-edgar","filing":"0001478242-17-000007","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1121897/000147824217000007/edgar.xml","form_type":"4"}},{"id":4515593,"issuer":{"id":3058,"kind":"organization","name":"IQVIA HOLDINGS INC.","symbol":"IQV"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2016-12-20T21:29:02.000Z","date":"2016-12-16","kind":"tax_withholding","acquired":false,"shares":4339,"price":77.88,"value":337921.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects shares withheld for taxes upon the vesting of 9,094 RSUs on December 16, 2016."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This amount includes 27,280 RSUs granted on December 16, 2015, and 7,732 RSUs converted on October 3, 2016 from PUs originally issued to the reporting person on March 3, 2016."}],"balance_after":39767,"source":{"system":"sec-edgar","filing":"0001478242-16-000013","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1121897/000147824216000013/edgar.xml","form_type":"4"}},{"id":4587583,"issuer":{"id":3058,"kind":"organization","name":"IQVIA HOLDINGS INC.","symbol":"IQV"},"owners":[{"id":31065,"kind":"person","name":"McDonnell Michael R.","position":1,"cik":"0001121897","reported_name":"MCDONNELL MICHAEL R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2016-10-04T20:39:44.000Z","date":"2016-10-03","kind":"grant","acquired":true,"shares":7732,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Issuance to the reporting person of restricted stock units (\"RSUs\") under the Quintiles IMS Holdings, Inc. 2013 Stock Incentive Plan (f/k/a the Quintiles Transnational Holdings Inc. 2013 Stock Incentive Plan) upon the conversion, at the effective time of the merger between Quintiles Transnational Holdings Inc. and IMS Health Holdings, Inc., of performance units (\"PUs\") originally issued to the reporting person on March 3, 2016.  The PUs converted into RSUs at 100% of target, and the resulting RSUs will vest in full on December 31, 2018, the end of the original performance period of the PUs that were converted."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This amount includes 36,374 RSUs granted on December 16, 2015 and 7,732 RSUs converted on October 3, 2016 from PUs originally issued to the reporting person on March 3, 2016."}],"balance_after":44106,"source":{"system":"sec-edgar","filing":"0001209191-16-144306","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1121897/000120919116144306/doc4.xml","form_type":"4"}}]}